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Borna disease virus (BDV) is a non-segmented, negative-strand RNA virus that replicates and
transcribes its genome in the nucleus of infected cells. It uses the cellular splicing machinery to
generate a set of alternatively spliced mRNAs from the 2–8 and 7–1 kb primary transcripts, each
harbouring two introns. To determine whether splicing of these transcripts is regulated by viral
factors, the extent of splicing was studied in infected cells and COS-7 cells transiently transfected
with plasmids encoding the 2–8 kb RNA of BDV. Unspliced RNA was found to be the most abundant
RNA species in infected cells, whereas viral transcripts lacking both introns were only found in
minute amounts. In sharp contrast, plasmid-derived 2–8 kb RNA was predominantly intron 1-
spliced and double-spliced. Co-expression of the BDV proteins P, N and X did not influence splicing
of plasmid-expressed 2–8 kb RNA. Furthermore, the splicing pattern did not change when the
2–8 kb RNA was expressed in BDV-infected cells. Based on these results we speculate that splicing
of authentic BDV transcripts is tightly linked to transcription by the viral polymerase.
Introduction
Most pre-mRNAs are spliced and polyadenylated prior to
their nuclear export (Nakielny & Dreyfuss, 1997). Unspliced
host pre-mRNAs are normally retained in the nucleus and
degraded ; however, in many viral systems cytoplasmic
accumulation of unspliced or incompletely spliced RNAs is
essential for translation of certain viral proteins and particle
assembly. Thus, mechanisms have evolved that facilitate
nuclear export of intron-containing viral RNAs (Cullen,
1998 ; Emerman & Malim, 1998 ; Trono, 1998 ; Whittaker &
Helenius, 1998). In human immunodeficiency virus type 1
(HIV-1) splicing of viral RNAs is circumvented by the activity
of the virus-encoded Rev protein (Cullen, 1998 ; Emerman &
Malim, 1998 ; Trono, 1998). This protein specifically binds to
intronic sequences of HIV-1 RNAs, the Rev response element
(RRE), and transports the bound RNA into the cytoplasm via
the nuclear pore complex (Cullen, 1998 ; Daly et al.,
1989 ; Emerman & Malim, 1998 ; Fischer et al., 1994, 1995 ;
Meyer & Malim, 1994 ; Trono, 1998). The latter activity
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requires the leucine-rich region of the nuclear export sequence
(NES) of Rev (Fischer et al., 1995 ; Meyer & Malim, 1994).
Mason–Pfizer monkey virus promotes the nuclear export of its
unspliced RNAs by a cis-acting element (Bray et al., 1994 ; Ernst
et al., 1997 ; Pasquinelli et al., 1997 ; Tabernero et al., 1997). The
function of this constitutive transport element depends entirely
on cellular factors (Gruter et al., 1998 ; Pasquinelli et al., 1997).
Cis-acting elements that enhance the cytoplasmic accumulation
of unspliced or incompletely spliced RNAs are also found in
hepatitis B virus (Huang & Liang, 1993 ; Huang & Yen, 1994)
and herpes simplex virus type 1 (Greenspan & Weissman,
1985 ; Liu & Mertz, 1995). In influenza virus-infected cells
nucleocytoplasmic transport of viral and cellular RNAs and
pre-mRNA splicing are regulated by the viral NS1 protein
(Alonso-Caplen et al., 1992 ; Chen et al., 1999 ; Fortes et al.,
1994 ; Lu et al., 1994).
Unlike other non-segmented negative-strand RNA viruses,
Borna disease virus (BDV) replicates and transcribes the
genome in the nucleus (Briese et al., 1992 ; Cubitt & de la Torre,
1994). Four major subgenomic RNAs (1–2, 0–8, 2–8 and 7–1 kb
RNA) are transcribed from three transcription units of the BDV
genome (Briese et al., 1994 ; Schneemann et al., 1994). Whereas
the 1–2 kb RNA, encoding the nucleoprotein (N), is mono-
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cistronic, all the other RNAs are multicistronic. The 0–8 kb
RNA encodes the phosphoprotein (P) and the X-Protein. The
2–8 kb RNA contains the ORFs for the putative matrix protein
(M) and the glycoprotein (G). The 7–1 kb RNA encodes the
polymerase (L) as well as M and G (Briese et al., 1994). The 2–8
and 7–1 kb RNAs are co-terminal at the 5« end but differ in
length due to transcriptional readthrough at a termination
signal (Schneemann et al., 1994). Since only about 3%
readthrough is observed at this termination signal, the 2–8 kb
RNA represents the major transcript of the third transcription
unit (Schneemann et al., 1994). Expression of M and G from the
2–8 kb RNA, and L from 7–1 kb RNA, are regulated by splicing
(Cubitt et al., 1994b ; Schneider et al., 1994). Whereas intron 1
is located within the M-ORF, intron 2 is found within the
ORFs for G and L. Therefore, transcripts retaining intron 1
serve primarily as mRNAs for M. Splicing of intron 1 results in
the disruption of the M-ORF, leaving a minicistron encoding
only eight amino acids, which enhances expression of G
(Schneider et al., 1997a). Splicing of intron 2 creates the
functional L-ORF in the 7–1 kb RNA (Schneider et al., 1994).
Additional splicing of intron 1 is most likely required to
facilitate initiation at the AUG of the L-ORF. Thus, differential
splicing of both introns is critical for balanced expression of the
viral proteins M, G and L.
Little is known about the cytoplasmic levels of the various
splice forms of BDV RNAs (Cubitt et al., 1994b ; Schneider et
al., 1994, 1997b). It is unclear whether virus-specific factors}
elements are involved in the regulation of splicing. First
indications that such factors might be implicated emerged in a
recent study where a cis-acting RNA element located within
the 3« non-coding region of the 2–8 kb RNA was found to be
important for efficient cytoplasmic accumulation of unspliced
RNA (Schneider et al., 1997b).
We have examined levels of unspliced and spliced BDV
transcripts in infected cells and cells transfectedwith expression
constructs encoding the 2–8 kb RNA. BDV-encoded transcripts
were spliced less efficiently than those encoded by expression
constructs. The splicing efficiency of transcripts generated
from expression constructs was similar in uninfected and
infected cells. These findings suggest that splicing of BDV-
encoded transcripts may be co-transcriptionally regulated.
Methods
+ Cell culture and transient transfection of plasmid DNA. C6,
COS-7, MDCK, Vero and Oligo (OL) cells were cultured in Dulbecco’s
modified Eagle’s medium containing 10% FCS. OL cells were kindly
provided by Georg Pauli (Robert Koch Institute, Germany). Transient
transfections of COS-7 and Vero cells were carried out with 2 or 10 lg
plasmid DNA for six-well or 64 cm# plates, respectively, using
Lipofectamine (GibcoBRL) according to the manufacturer’s recommen-
dations.
+ Construction of plasmids. Plasmids pRPAwt and pRPAmt were
used for in vitro transcription of the wild-type RNase protection assay
(RPA) probe (RPAwt) or the mutant RPA probe (RPAmt) and were
generated as follows : To create pRPAwt, the HindIII–EcoRI fragment of
pRPA-1 (Schneider et al., 1997b), encoding part of the BDV M}G-ORFs
corresponding to nucleotides 1975–2510 of BDV strain He}80 (Cubitt et
al., 1994a), was cloned into pGEM-4 (Promega). Plasmid pRPAmt was
derived from pRPAwt by replacing six nucleotides of exon 2 (ccagag to
gttaac) of the M}G-ORFs corresponding to nucleotides 2216–2221 of
BDV strain He}80 using the Quick-mutagenesis protocol (Roche
Biochemicals). To clone the mutated DNA into plasmid pRc2.8 encoding
the 2–8 kb RNA of BDV (Schneider et al., 1997b), the BbsI–Bst1107I
fragment of pRPAmt, harbouring the respective region, was first
subcloned into plasmid pBS-XbaI containing the XbaI fragment of pRc2.8,
resulting in plasmid pBS-XbaI}mt. In a final step, the XbaI fragment of
pRc2.8 was replaced with the corresponding fragment of pBS-XbaI}mt,
resulting in plasmid pRc2.8mt. Plasmids pRc2.6 and pRc1.5 were obtained
by ligating NotI fragments of plasmids p2.6 and p1.5 (kindly provided by
Patrick Schneider, UC-Irvine, USA) encoding either the 2–6 kb RNA or
1–5 kb RNA of BDV strain He}80 into the corresponding sites of pRc2.8.
Plasmid pG3T.t was used to generate the RPA probe for detection of
SV40 t-antigen mRNAs in COS-7 cells. Plasmid pG3T.t was prepared by
cloning a PCR product including the sequences from position 4541 to
4978 in SV40 DNA into pGEM-3 (Promega). The primers used for
amplification (5« gcgcgcgaattcggaagatggagtaaaatatgc and 5« gcgcg-
cggatccgctcccattcatcagttcc) contained additional EcoRI and BamHI sites.
The PCR product was digested with both enzymes and cloned into EcoRI-
and BamHI-digested pGEM-3 DNA. Plasmids encoding the N-ORF
(pCMV-N) and X-ORF (pCMV-X) of BDV strain He}80 under control of
a CMV promoter were kindly provided by Ju$ rgen Hausmann, University
of Freiburg, Germany.
+ RNA preparation. Isolation of poly(A)+ RNA from total RNA was
carried out using the Oligotex mRNA spin column protocol from
Qiagen. RNA from cytoplasmic and nuclear fractions were obtained as
described (Nevins, 1980). Briefly, cells were trypsinized 48 h post-
transfection, harvested and washed twice with PBS. Cell pellets were
lysed in 500 ll Iso-Hi-pH containing 10 mM Tris–HCl (pH 8–4), 140 mM
NaCl, 1–5 mM MgCl
#
and 0–5% Nonidet P-40 (0–5%, v}v) for 5 min at
4 °C. Nuclear and cytoplasmic fractions were subsequently separated by
centrifugation at 1000 g for 3 min at room temperature. The crude
nuclear pellet was immediately washed once in 500 ll Iso-Hi-pH and
once in 500 ll Iso-Hi-pH containing 0–33% (w}w) sodium deoxycholate
and 0–66% (v}v) Tween 40 to obtain the final nuclear fraction. Total
RNA and RNA from both cytoplasmic and nuclear fractions was
prepared with peqGOLD TriFast (Peqlab) as recommended by the
manufacturer.
+ In vitro transcription and RNase protection assay. Run-off
transcriptions were performed at 37 °C in a total volume of 20 ll
containing 0–2 lg linearized DNA, 1‹T7 transcription buffer (Roche
Biochemicals), 28 U RNasin (Amersham), 0–5 lM ATP, GTP and CTP,
0–05 lM UTP (Pharmacia), 3 U T7 Polymerase (MBI Fermentas) and
1 lCi $#P-labelled rUTP (3000 Ci}mmol ; Amersham) for 90 min. For
subsequent DNase digestion the total volume was raised to a final
volume of 30 ll with 1‹transcription buffer including 4 U RNase-free
DNase (Ambion) and incubated for 30 min at 37 °C. Purification of the
$#P-labelled RNA and subsequent RPA reactions was done as described
in Stalder et al. (1998). RPA was performed with approximately 1–4‹10&
c.p.m. $#P-labelled RPA-probe and either 5 lg of total RNA or RNA
from the cytoplasmic fraction, 1 lg of RNA from the nuclear fraction or
poly(A)+ RNA, prepared from 50 lg of total RNA. Digestion of
unhybridized RNA was performed using 0–02 lg per sample RNase A
(Ambion) and 16 U per sample RNase T1 (Roche Biochemicals). The RPA
signals were quantified with a phosphorimager (FUJIX BAS1000) using
the software package MacBAS version 2.2 (Fuji). Ratios of unspliced and
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spliced RNA species of one RPA reaction were calculated based on the
signal intensities and were normalized to the number of U residues in the
respective protected probe fragments to account for the bias of signal
intensities caused by the different lengths of the RNA fragments. RPA
size markers were obtained by PCR using pRc2.8 and primers C1 (5«
ttgtaggagggacttcacgg), C2 (5« ctgtagctaccaaaggatcc), C3 (5« tgaaagag-
cctctgcag) and C4 (5« ctcgcatgaaatgacattt), resulting in four DNA
fragments of length 535, 484, 434 and 383 bp, respectively. These
amplification products (20 ng per fragment) were used in the RPA
reaction to generate fragments of the radiolabelled RPA probe cor-
responding to the length of the expected unspliced and spliced viral RNA
species.
+ Virus stock preparation and titration. Virus stock from OL cells
persistently infected with BDV strain He}80 (Cubitt et al., 1994a) was
prepared as described in Briese et al. (1992) with slight modifications.
Briefly, 25 confluent 90 mm plates cells were washed with 20 mM HEPES
(pH 7–4) and incubated with 10 ml 20 mM HEPES (pH 7–4) containing
250 mM MgCl
#
and 1% FCS for 1–5 h at 37 °C. Subsequently,
supernatants were harvested and centrifuged twice at 2500 g for 5 min
to remove cell debris. Virus particles were concentrated by ultra-
centrifugation for 1 h at 20 °C at 80000 g onto a 20% sucrose cushion
containing 20 mM HEPES (pH 7–4) and 1% FCS. Virus-containing pellets
were resuspended in PBS to approximately 10’ f.f.u.}ml. Persistent BDV
infection was established by an initial infection of 10& C6 , Vero , MDCK
or COS-7 cells with 10% f.f.u. of virus stock followed by at least 5 weeks
of passaging. Complete infection of the cultures was monitored by
immunofluorescence assay as described by Hallensleben & Staeheli
(1999).
Results
Ratios of spliced and unspliced viral mRNA species in
BDV-infected cells
Unspliced and spliced viral transcripts in the cytoplasm of
BDV-infected COS-7 cells were detected by RPA using an
Fig. 1. Levels of spliced and unspliced
viral RNA species in COS-7 cells
persistently infected with BDV. RPAs
were performed using a 535 nt long RNA
probe complementary to the M/G ORF of
strain BDV He/80 (lane 1). RNA samples
(5 lg) were prepared from total cell
lysates (lane 5) or from cytoplasmic (lane
6) and nuclear (lane 7) fractions of BDV-
infected COS-7 cells. In lane 8, poly(A)+
RNA prepared from 50 lg of total RNA of
BDV-infected COS-7 cells was used in
the RPA. Controls for RNase digestion
efficiency were 10 lg of tRNA (lane2)
and 5 lg of total RNA from uninfected
COS-7 cells (lane 4). Lane 3 contains
markers corresponding to the expected
unspliced and spliced transcripts
protected by the RNA probe. The
potential repertoire of RNA species is
indicated (right-hand side).
Table 1. Quantification of RPA signals of cytoplasmic
unspliced and spliced RNA species from various BDV-
infected cell lines
Splice form (%)
Cell line… C6 Vero COS-7 MDCK OL
Unspliced 47 72 48 31 65
Intron 1-spliced 33 16 19 30 18
Intron 2-spliced 12 8 26 22 13
Double-spliced 8 4 7 16 4
RNA probe (RPAwt) complementary to a part of intron 1,
exon 2 and intron 2 of the M}G ORFs (nt–1975–2510).
Unspliced RNA was the most abundant RNA species in both
total RNA and the cytoplasmic fraction of BDV-infected COS-
7 cells followed by lower levels of intron 1- or intron 2-spliced
RNAs and minute amounts of RNAs lacking both introns (Fig.
1, lanes 5 and 6). Nearly all RNA detected in the nuclear
fraction was unspliced (Fig. 1, lane 7). Quantification of the
cytoplasmic RPA signals revealed that 48% of the RNA
species were unspliced, 19% intron 1-spliced, 26% intron 2-
spliced and 7% double-spliced (Table 1). As a control to assess
whether the unspliced RNA observed in the cytoplasmic
fraction was viral mRNA and not antigenomic viral RNA that
leaked from the nucleus during the fractionation procedure,
poly(A)+ RNA from BDV-infected COS-7 cells was used for
RPA. The ratios of unspliced and spliced transcripts were
similar in experiments with poly(A)+ RNA and RNA obtained
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Fig. 2. Plasmid-encoded 2–8 kb RNA is preferentially intron 1-spliced and double-spliced. Levels of unspliced and partially
spliced BDV RNA species in infected COS-7-cells (lane 5) and uninfected COS-7-cells transiently transfected with expression
plasmids encoding either the 2–8 kb RNA (pRc2.8, lanes 6–11) or mutant 2–8 kb RNAs lacking intron 1 (pRc2.6, lanes 12 and
13) or intron 2 (pRc1.5, lanes 14 and 15) were analysed by RPA (see Fig. 1). RNA samples (5 lg) used in lanes 9–15 were
pretreated with DNase I. The source of RNA samples is indicated: t, total cell lysate ; c, cytoplasmic fraction ; n, nuclear fraction.
Controls for RNase digestion efficiency were 10 lg of tRNA (lane 2) and 5 lg of total RNA from uninfected COS-7 cells (lane
4). Lane 3 contains markers corresponding to the expected unspliced and spliced transcripts protected by the RNA probe. The
potential repertoire of RNA species is indicated (right-hand side).
from the cytoplasmic fraction (Fig. 1, lanes 6 and 8). Quanti-
fication by RPA confirmed this similarity (data not shown).
To address the question whether the ratios of the different
splice forms of BDV transcripts may vary with host cell type,
RPAs were performed with cytoplasmic RNA extracted from
infected renal (Vero and MDCK) and neural (C6 and OL) cell
lines. With the exception of BDV-infected COS-7 cells, where
levels of the intron 2-spliced RNAs were slightly higher than
intron 1-spliced RNAs, decreasing concentrations of unspliced,
intron 1-spliced, intron 2-spliced and double-spliced RNAs
were observed in BDV-infected C6, Vero, MDCK and OL cells
(Table 1). In summary, these data indicate that a characteristic
splicing pattern is maintained in all tested BDV-infected cells.
Splicing of plasmid-encoded 2–8 kb RNA differs from
that of virus-encoded transcripts
To test the hypothesis that the ratio of spliced and
unspliced RNAs in BDV-infected cells is controlled by intrinsic
features of the viral 2–8 kb or 7–1 kb RNA we transfected
plasmid pRc2.8, which expresses only the 2–8 kb RNA, into
COS-7 cells (Fig. 2). Two days after transfection we prepared
RNA from total cell lysates or from cytoplasmic and nuclear
extracts, and analysed the RNA samples for the presence of the
various splice forms using the RPA probe described above. As
residual plasmid DNA in the RNA preparations would provide
signals indistinguishable from unspliced 2–8 kb RNA, parallel
RNA samples were treated with RNase-free DNase prior to the
RPA. The importance of this control is illustrated by the
presence of a strong signal at the position of unspliced
Table 2. Quantification of RPA signals of unspliced and
spliced RNA species
COS-7 cells were infected with BDV or transfected with plasmids
expressing the viral 2–8 kb RNA (pRc2.8) shown in Fig. 2 and the
2–6 kb RNA (pRc2.6) or the 1–5 kb RNA (pRc1.5). Values are means of
three independent experiments.
Splice form (%)
COS-7… BDV pRc2.8 pRc2.6 pRc1.5
Unspliced 47 9 – –
Intron 1-spliced 20 39 52 –
Intron 2-spliced 28 4 – 33
Double-spliced 5 49 48 67
transcripts shown in Fig. 2, particularly in the total and the
nuclear RNA fraction (lanes 6 and 8) ; this signal was indeed
substantially reduced in DNase-treated samples (lanes 9 and
11). All four splice forms were detected in total RNA and the
cytoplasmic fraction (Fig. 2, lanes 6, 7, 9 and 10). Transcripts
originating from 2–8 kb RNA expression plasmids were
preferentially intron 1-spliced and double-spliced (Fig. 2, lane
10). In contrast, higher levels of unspliced transcripts were
observed in BDV-infected COS-7 cells (Fig. 2, lane 5).
Cytoplasmic concentrations of unspliced and intron 2-spliced
transcripts were 9 and 4%, respectively, as compared to 47 and
28% in BDV-infected COS-7 cells (Table 2).
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Fig. 3. The splicing of a plasmid-encoded 2–8 kb RNA variant is similar in uninfected and BDV-infected COS-7 cells. Uninfected
or BDV-infected COS-7 cells were transiently transfected with plasmids expressing either the wild-type form of the 2–8 kb RNA
(lanes 6, 8, 15 and 17) or mutant 2–8 kb RNA (lanes 7, 9 16 and 18). The mutant RNA is identical to wild-type 2–8 kb RNA
with the exception of six nucleotide exchanges within exon 2. RPAs were performed using probes complementary to either
wild-type 2–8 kb RNA (RPAwt, lanes 1–9) or mutant 2–8 kb RNA (RPAmt, lanes 10–18). Lane 3 contains markers
corresponding to the expected unspliced and spliced transcripts protected by the RNA probe. Lane 12 represents the RPA
reaction product with the marker material used in lane 3. Arrows indicate signals from specifically degraded RPA probes due to
the six nucleotide mismatch between wild-type and mutant RNAs. Controls for RNase digestion efficiency were 10 lg of tRNA
(lanes 2 and 11) and 5 lg of total RNA from uninfected COS-7 cells (lanes 4 and 13). The potential repertoire of RNA species
is indicated (right-hand side).
To investigate splicing efficiency of each of the two introns,
COS-7 cells were transiently transfected with either plasmid
pRc2.6, which expresses a 2–6 kb RNA that lacks intron 1, or
plasmid pRc1.5, which expresses a 1–5 kb RNA that lacks
intron 2. Two days post-transfection, RNA samples from the
cytoplasmic fraction were subjected to RPA. As shown in Fig.
2, the 2–6 kb RNA (lane 12) and the 1–5 kb RNA (lane 14) were
both partially spliced. Quantification of the corresponding
RPA signals from three independent experiments revealed that
67% of 1–5 kb and 48% of 2–6 kb RNAs lack their cor-
responding introns (Table 2). These data suggested that intron
1 was more efficiently spliced than intron 2.
Splicing of cDNA-derived 2–8 kb RNA remains
unchanged in the presence of viral proteins
The differences in the splice ratios of cDNA-derived 2–8 kb
RNA and virus-encoded RNAs could be explained by viral
factors. Pilot experiments indicated that co-transfection of
plasmids encoding the viral proteins N, P or X either alone or
in combination into Vero cells expressing the viral 2–8 kb
RNA, did not influence splicing of intron 1 and intron 2 (data
not shown). To address the possibility that other transacting
viral factors might be missing, we studied splicing of the 2–8 kb
RNA in BDV-infected COS-7 cells. To facilitate discrimination
between virus and plasmid-encoded RNAs we used a plasmid
(pRc2.8mt) that coded for a mutant form of the 2–8 kb RNA
carrying six nucleotide exchanges in exon 2. RNA samples
were analysed 48 h post-transfection by RPA using RPAmt as
a probe, which is complementary to mutated 2–8 kb RNA.
Since virus-encoded RNAs do not perfectly match RPAmt, the
RNases cleave the probe into two fragments of smaller size. As
shown in Fig. 3, expression of the mutated 2–8 kb RNA
revealed a splice pattern in BDV-infected COS-7 cells (lane 18)
similar to that observed in uninfected COS-7 cells (lane 16).
This pattern was identical to that seen in COS-7 cells
transfected with pRc2.8, which encodes the wild-type form of
the 2–8 kb RNA (lane 6). Comparable splice ratios were
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Fig. 4. Levels of unspliced and spliced t-Ag mRNA remain unchanged in
BDV-infected and uninfected COS-7 cells. RPAs were performed using a
437 nt long RNA probe (lane 1) complementary to the SV40 early
transcripts including the t-Ag mRNA (340 nt). RNA samples (5 lg) were
prepared from total cell lysates of uninfected and BDV-infected COS-7
cells (lanes 5 and 6). Controls for RNase digestion efficiency were 5 lg of
tRNA (lane2), 5 lg of total RNA from uninfected and BDV-infected C6
cells lacking the endogenous SV40 transcription unit (lanes 3 and 4). The
positions of unspliced pre-mRNA and spliced t-Ag mRNA are indicated by
arrows.
observed in uninfected and BDV-infected COS-7 cells using
different amounts of pRc2.8mt per transfection (ranging from
0–1 to 1 lg; data not shown). Thus, BDV infection did not
seem to influence splicing of cDNA-derived 2–8 kb RNA.
However, expression of the mutant form of the 2–8 kb RNA
resulted in a subtle change in the splice pattern of virus-
encoded RNAs (compare Fig. 3, lane 5 and 9) : the amounts of
intron 1-spliced and double-spliced transcripts seemed to
increase under these conditions.
We further analysed whether virus replication may
influence splicing of host cell-derived transcripts by com-
parison of the spliced and unspliced levels of t-Ag pre-mRNA
in COS-7 cells carrying the SV40 early region in the genome.
Similar concentrations of t-Ag mRNA and unspliced transcripts
were observed in the absence (Fig. 4, lane 5) or presence of
BDV (Fig. 4, lane 6), suggesting that splicing of cellular RNAs
is not affected in general.
Discussion
We have shown that splicing of BDV transcripts in infected
cells is quantitatively different from splicing in cells transfected
with a plasmid encoding the 2–8 kb BDV RNA. Whereas
transcripts generated by the viral polymerase were pre-
dominantly unspliced, the majority of plasmid-encoded 2–8 kb
RNAs were either intron 1-spliced or double-spliced. Based on
these differences and the observations that splicing of plasmid-
derived 2–8 kb RNA is unchanged in virus-infected cells, we
propose that BDV cotranscriptionally regulates the splicing of
its own primary transcripts.
Attenuation of transcription at the gene borders is a feature
of nonsegmented negative-strand RNA viruses that results in
a concentration gradient of mRNAs encoding sequential ORFs
(Conzelmann, 1998). The pattern of gene expression is more
complex in BDV because M and G are derived from the
multicistronic 2–8 and 7–1 kb RNAs. The unspliced and intron
2-spliced mRNAs that encode M are more abundant in the
cytoplasm of BDV-infected cells than the intron 1-spliced
mRNAs that encode G. Thus, BDV establishes a concentration
gradient similar to that observed in other Mononegavirales at
least in part by regulating the splicing of intron 1 and intron 2.
A comparison with plasmid-encoded 2–8 kb RNA indicates
that splicing in BDV-infected cells is not solely due to intrinsic
features of the viral RNA. We therefore speculate that BDV-
encoded factors may interfere with splicing of both introns.
This could be achieved by promoting nuclear export of
unspliced and partially spliced mRNAs. Intrinsically inefficient
splicing of intron 2 might cause the preferential cytoplasmic
accumulation of intron 1-spliced RNA. This view is supported
by our observation that plasmid-encoded splice intermediates
lacking intron 1 were not spliced as efficiently as those
intermediates lacking intron 2. However, recent observations
indicate that transcription and processing of the cellular
polymerase II transcripts is tightly linked, most likely due to
the spatial relationship of the different enzymes involved
(McCracken et al., 1997). Therefore, an alternative explanation
for the preferential splicing of the plasmid-derived transcripts
might be that these transcripts are generated in an environment
more active in RNA processing than the compartment in which
BDV transcription occurs.
In this study we were unable to confirm the results of our
earlier report wherein the unspliced plasmid-encoded 2–8 kb
RNA predominantly accumulated in the cytoplasm due to an
RNA element located in the 3« non-coding region (Schneider et
al., 1997b). Since we used the same detection technique (RPA),
plasmid (pRc2.8) and cell type (COS-7 cells), we propose that
the differences may relate to the fact that the RNA samples in
this study were subjected to DNase treatment before analysis
by RPA. Furthermore, expression of 2–8 kb RNA lacking the
putative export sequence did not result in an enhanced
cytoplasmic accumulation of spliced RNA (C. Jehle, N.
Horscroft, W. I. Lipkin & M. Schwemmle, unpublished results),
indicating that regulation of viral RNA splicing in infected cells
most likely occurs via other mechanisms and not as proposed
through the 3« non-coding region (Schneider et al., 1997b).
One alternative is that nuclear export of unspliced BDV
transcripts may be coupled to transcription by the viral
polymerase. Support for this hypothesis was found in the
observation that the cytoplasmic levels of unspliced 2–8 kb
RNA originating from transfected plasmid DNA were low in
both infected and uninfected COS-7 cells (Fig. 3, lanes 16 and
18). Intriguingly, we detected subtle changes in virus-encoded
RNA species when large amounts of 2–8 kb RNA were
expressed from transfected plasmids (Fig. 3, lane 9), suggesting
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interference with viral factors required for regulation of
splicing.
BDV infection does not appear to interfere with the
processing of cellular intron-containing RNA polymerase II
transcripts including t-antigen pre-mRNAs in COS-7 cells (Fig.
4) or trKc pre-mRNAs (Valenzuela et al., 1993) in brains of
newborn rats (C. Sauder, personal communication). Regulation
of differential splicing at the co-transcriptional level provides a
mechanism for control of BDV gene expression that does not
compromise the viability of the host cell or the potential for
establishment of persistent infection.
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